Back to HGSI Stock Lookup

HGSI Related

Jul 30, 2012 08:37 AM GlaxoSmithKline (GSK) Announces Results of Initial Tender Offer for Human Genome Sciences (HGSI)
Jul 27, 2012 07:46 AM Amgen (AMGN) Said to Make $7B Bid for Human Genome (HGSI) in 2010
Jul 23, 2012 08:15 AM Maxim Cuts Human Genome Sciences (HGSI) to Hold
Jul 23, 2012 07:18 AM Stocks with implied volatility movement; UA HGSI
Jul 20, 2012 04:11 PM Top 10 News Items 7/16-7/20: Bernanke Points to Slower Than Expected Growth; A Wave of Tech Earnings; Marissa Mayer Named New Yahoo! CEO
Jul 17, 2012 09:57 AM Summer Street Downgrades Human Genome Sciences (HGSI) to Neutral
Jul 17, 2012 07:14 AM JPMorgan Downgrades Human Genome Sciences (HGSI) to Neutral
Jul 16, 2012 10:31 AM Baird Downgrades Human Genome Sciences (HGSI) to Neutral; Story Now Played Out
Jul 16, 2012 10:11 AM Notable Mergers and Acquisitions of the Day 07/16: (GSK)/(HGSI) (PRX) (MMUS) (CONM)
Jul 16, 2012 09:45 AM Shares of Human Genome Sciences (HGSI) resume trading up ~5%
Jul 16, 2012 09:36 AM Shares of Human Genome Sciences (HGSI) to resume trading at 9:45am ET
Jul 16, 2012 09:25 AM Pre-Open Winners 7/16: (PRX) (AUTH) (HGSI) Higher (more...)
Jul 16, 2012 09:17 AM Glaxo (GSK) Confirms Offer for Human Genome (HGSI), Deal Valued at $14.25/Share in Cash
Jul 16, 2012 09:16 AM Human Genome Sciences Inc. (HGSI) acquired by GSK for $14.25/share
Jul 16, 2012 09:15 AM Human Genome Sciences Inc. (HGSI) halted news pending
Jul 16, 2012 06:37 AM Human Genome Sciences (HGSI) Agrees to $14/Share Takeover from GSK (GSK) - Reports
Jul 10, 2012 07:03 AM Human Genome (HGSI) Announces Resubmission of Raxibacumab BLA; PDUFA Date Set for Dec. 15th
Jul 9, 2012 09:21 AM Pre-Open Winners 7/9: (FX) (AGP) (CNC) Higher (more...)
Jul 9, 2012 08:44 AM A Celgene (CELG) / Human Genome Sciences (HGSI) Deal Seen as Unlikely
Jul 6, 2012 07:05 AM Human Genome (HGSI) volatility decreases into GlaxoSmithKline’s July 20 expiration of tender
Jul 2, 2012 02:15 PM S&P Biotech EFT (XBI) Pops on Amylin (AMLN) Buyout News
Jun 29, 2012 09:11 AM Human Genome (HGSI) Says Less than 1% of Shares Tendered in Glaxo (GSK) Offer
Jun 29, 2012 07:09 AM Glaxo (GSK) Extends $13/Share Tender for Human Genome (HGSI)
Jun 29, 2012 06:59 AM Human Genome (HGSI) Could Get 15% More in Takeover Bid - Analyst
Jun 15, 2012 09:27 AM Pre-Open Winners 6/15: (YPF) (LNG) (NAV) (more...)
Jun 15, 2012 08:19 AM Is Human Genome (HGSI) Getting Desperate for a Deal?
Jun 15, 2012 07:12 AM ATTENTION, GLAXO (GSK): Human Genome's (HGSI) Cut-Off Date is July 16th, Will Provide Details to Interested Parties
Jun 15, 2012 06:41 AM Human Genome Sciences (HGSI) Calls It; Says July 16th Deadline for Bids (GSK)
Jun 14, 2012 07:58 AM JMP Securities Upgrades Human Genome Sciences (HGSI) to Market Perform
Jun 12, 2012 08:31 AM BioMarin (BMRN) Higher as Takeover Chatter Swirls
Jun 8, 2012 10:40 AM Notable Mergers and Acquisitions of the Day 06/08: (CHK)/(CHKM) (HGSI)/(GSK) (CTFO)
Jun 8, 2012 09:28 AM Human Genome (HGSI) Rejects $13/Share Bid from Glaxo (GSK); Calls It 'Inadequate'
Jun 8, 2012 09:27 AM Human Genome (HGSI) Comments on GlaxoSmithKline's (GSK) Announcement to Extend Tender Offer
Jun 8, 2012 08:38 AM UPDATE: GlaxoSmithKline (GSK) Extends Tender Offer for Human Genome (HGSI) to June 29th
Jun 1, 2012 01:47 PM UPDATE: Human Genome (HGSI) Rejects GSK's (GSK) $13/Share Offer
May 31, 2012 07:21 AM Stocks with implied volatility below IV index mean; HGSI AMLN
May 30, 2012 10:19 AM Human Genome (HGSI) Shares Moving as Reuters Says Glaxo (GSK) Wants to Replace Entire Board
May 30, 2012 07:11 AM Stocks with implied volatility below IV index mean; HGSI ARBA
May 24, 2012 11:25 AM Notable Analyst Rating Changes 05/24: (PPG) (WPI) (DUK) Upgraded; (BHI) (HGSI) (COG) Downgraded
May 24, 2012 07:35 AM BMO Capital Downgrades Human Genome Sciences (HGSI) to Market Perform
May 17, 2012 01:17 PM Glaxo (GSK) Comments on Human Genome (HGSI) Bid Rejection; Will Continue with $13/Share Tender
May 17, 2012 07:06 AM Human Genome Sciences (HGSI) Unanimously Rejects GlaxoSmithKline (GSK) Offer
May 14, 2012 03:58 PM Barclays Maintains an 'Equalweight' on Human Genome Sciences (HGSI); Looking At $15/Share For GSK To Seal The Deal
May 10, 2012 11:20 AM Notable Analyst Rating Changes 05/10: (TPX) (PRU) (KERX) Upgraded; (VRTX) (HGSI) (ORCL) Downgraded
May 10, 2012 07:40 AM Leerink Swann Downgrades Human Genome Sciences (HGSI) to Market Perform; Limited Visibility
May 9, 2012 10:53 AM Notable Mergers and Acquisitions of the Day 05/09: (BBBY)/(CPWM) (GSK)/(HGSI) (NKBP)
May 9, 2012 10:08 AM Human Genome Sciences (HGSI) to Review Offer from Glaxo (GSK)
May 9, 2012 09:29 AM Pre-Open Movers 5/9: (SODA) (DMD) (DF) Higher; (CQB) (DVA) (STEC) Lower (more...)
May 9, 2012 06:52 AM GlaxoSmithKline (GSK) Commence $13/Share Tender Offer for Human Genome Sciences (HGSI)
Apr 27, 2012 07:17 AM Stocks with implied volatility below IV index mean; AMLN HGSI

Back to HGSI Stock Lookup